James Jackson, MD
Pain Medicine · Louisville, KYNPI 1063583268
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,900 of the $14,329 with a category attached, or 69.1%. Novartis accounts for 69.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $10,563 and has fallen 96.9% since, to $332 in 2025.
Across 144 payments — averaging $99.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$10K
- Abbott$2K
- Janssen Scientific Affairs, LLC$825
- AbbVie$444
- Si-bone, Inc.$323
- Protega Pharmaceutials Inc$257
- plus $846 from 12 others
What the payments were for
- Consulting fees$9,90069%
- Speaking & faculty fees$8256%
- Food & beverage$3,60425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 4 | $9,950 |
| Abbott | 79 | $1,684 |
| Janssen Scientific Affairs, LLC | 1 | $825 |
| AbbVie(2 entities) | 21 | $444 |
| Si-bone, Inc. | 4 | $323 |
| Protega Pharmaceutials Inc | 4 | $257 |
| Boston Scientific | 5 | $195 |
| Vertos Medical, Inc. | 1 | $139 |
| Amgen | 6 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $106 |
| Medical Device Business Services, Inc. | 1 | $90 |
| Vertex | 3 | $55 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $33 |
| SPR Therapeutics, Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Stryker | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COSENTYX$5,580
- QGE031$4,320
- Tremfya$825
- Proclaim Family of SCS IPGs$445
- mild Device Kit$139
How this compares
$14,329 in reported general payments places this provider in the 80th percentile of 90 pain medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 3,514 | $86,526 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 4,342 | $83,624 |
| OxycontinOxycodone Hcl | 77 | $83,009 |
| PercocetOxycodone Hcl/Acetaminophen | 11 | $36,577 |
| Oxycodone Hcl | 666 | $18,002 |
| Xtampza ErOxycodone Myristate | 17 | $17,599 |
| Fentanyl | 59 | $8,393 |
| Pregabalin | 85 | $5,734 |
| Gabapentin | 456 | $5,640 |
| Morphine Sulfate ErMorphine Sulfate | 148 | $4,052 |
| Meloxicam | 44 | $2,305 |
| AmantadineAmantadine Hcl | 16 | $2,225 |
| Hydromorphone Hcl | 54 | $1,759 |
| Methadone Hcl | 93 | $1,494 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 47 | $1,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $43 | $17,59917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 90 pain medicine providers in Kentucky.
Other pain medicine in Louisville
- Timothy BeachamLouisville$31K
- Lawrence PetersLouisville$13K
- Stephen YoungLouisville$12K
- Michael CronenLouisville$10K
- Darel BarnettLouisville$9K
- Anilkumar VinayakanLouisville$7K
- Carlos Perez-RuizLouisville$7K
- Jason LewisLouisville$6K
- Brooke BauerLouisville$5K
- Dominique RazeeqLouisville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.